VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q95967206  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235822.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q95967206‏
024 ‎‡a  0000-0002-6608-4695‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q95967206‏
100 0 ‎‡a  Andressa Souza‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Andressa Souza‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Effects of gestational and breastfeeding caffeine exposure in adenosine a1 agonist-induced antinociception of infant rats‏
670 ‎‡a  Author's Single exercise stress reduces central neurotrophins levels and adenosine A1 and A2 receptors expression, but does not revert opioid-induced hyperalgesia in rats‏
670 ‎‡a  Author's The Central Sensitization Inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor‏
670 ‎‡a  Author's Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System‏
909 ‎‡a  (orcid) 0000000266084695‏ ‎‡9  1‏
919 ‎‡a  effectsofgestationalandbreastfeedingcaffeineexposureinadenosinea1agonistinducedantinociceptionofinfantrats‏ ‎‡A  Effects of gestational and breastfeeding caffeine exposure in adenosine a1 agonist-induced antinociception of infant rats‏ ‎‡9  1‏
919 ‎‡a  centralsensitizationinventoryvalidatedandadaptedforabrazilianpopulationpsychometricpropertiesanditsrelationshipwithbrainderivedneurotrophicfactor‏ ‎‡A  The Central Sensitization Inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor‏ ‎‡9  1‏
919 ‎‡a  uliginosinbapossiblenewanalgesicdrugactsbymodulatingtheadenosinergicsystem‏ ‎‡A  Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System‏ ‎‡9  1‏
919 ‎‡a  singleexercisestressreducescentralneurotrophinslevelsandadenosinea1anda2receptorsexpressionbutdoesnotrevertopioidinducedhyperalgesiainrats‏ ‎‡A  Single exercise stress reduces central neurotrophins levels and adenosine A1 and A2 receptors expression, but does not revert opioid-induced hyperalgesia in rats‏ ‎‡9  1‏
996 ‎‡2  LC|no2022131690
996 ‎‡2  BLBNB|000360725
996 ‎‡2  BLBNB|000360344
996 ‎‡2  PTBNP|211749
996 ‎‡2  LC|n 84104225
996 ‎‡2  PTBNP|1525163
996 ‎‡2  J9U|987007341189405171
996 ‎‡2  LIH|LNB:CE_t_1;=BT
996 ‎‡2  ISNI|0000000383757385
996 ‎‡2  LC|n 83057105
996 ‎‡2  ISNI|0000000045026192
996 ‎‡2  PTBNP|1807495
996 ‎‡2  LC|no2007104394
996 ‎‡2  BNF|13465773
996 ‎‡2  CAOONL|ncf11168433
996 ‎‡2  NII|DA03134193
996 ‎‡2  ISNI|000000044076040X
996 ‎‡2  BLBNB|000603125
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏